Clincosm LogoSign in Get a demo

Neuroblastoma

Showing 26 - 50 of 393
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma Trial in Canada, United States (Eflornithine)

Recruiting
  • Neuroblastoma
  • Little Rock, Arkansas
  • +22 more
Jan 23, 2023

Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Neuroblastoma
  • GINAKIT Cells
  • +2 more
  • Houston, Texas
    Texas Children's Hospital
Jan 18, 2023

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Neuroblastoma Trial in Worldwide (Idasanutlin, Venetoclax,

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Phoenix, Arizona
  • +19 more
Jan 18, 2023

Neuroblastoma, Pediatric Cancer Trial in New York (Cyclophosphamide, Topotecan, Vincristine)

Recruiting
  • Neuroblastoma
  • Pediatric Cancer
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 11, 2023

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)

Completed
Has Results
  • Neuroblastoma
  • Medulloblastoma
  • San Diego, California
  • +14 more
Dec 28, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Genomic Structural Variation in Cancer Susceptibility

Active, not recruiting
  • Breast Cancer
  • +5 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 23, 2022

    Neuroblastoma, CNS Tumor, Sarcoma Trial in Columbus (Cabozantinib)

    Recruiting
    • Neuroblastoma
    • +2 more
    • Columbus, Ohio
      Nationwide Children's Hospital
    Dec 20, 2022

    Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

    Completed
    • Ependymoma
    • +9 more
    • Nivolumab
    • NKTR-214
    • Little Rock, Arkansas
    • +17 more
    Dec 8, 2022

    Synovial Sarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neuroblastoma Trial in United States (Afamitresgene

    Not yet recruiting
    • Synovial Sarcoma
    • +3 more
    • Afamitresgene autoleucel
    • Palo Alto, California
    • +3 more
    Dec 6, 2022

    Neuroblastoma Trial in New York (dietary supplement, drug, biological)

    Recruiting
    • Neuroblastoma
    • β-glucan
    • +2 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 5, 2022

    Melanoma, Neuroblastoma, Sarcoma Trial in New York (124I-Humanized 3F8)

    Active, not recruiting
    • Melanoma
    • +2 more
    • 124I-Humanized 3F8
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Dec 1, 2022

    Pediatric Neuroblastoma Treated With Lorlatinib

    Completed
    • Neuroblastoma
    • Philadelphia, Pennsylvania
    • +10 more
    Nov 17, 2022

    Neuroblastoma Trial in Lille, Lyon, Toulouse (PRRT with 177Lu-DOTATATE)

    Not yet recruiting
    • Neuroblastoma
    • PRRT with 177Lu-DOTATATE
    • Lille, France
    • +2 more
    Nov 8, 2022

    DOTATOC PET/CT for Imaging NET Patients

    Recruiting
    • Neuroendocrine Tumors
    • +15 more
    • 68Ga-DOTATOC PET/CT
    • 18F-FDG PET/CT
    • Vancouver, British Columbia, Canada
      BC Cancer
    Nov 2, 2022

    Neuroblastoma Trial in Cologne (antibody ch14.18, GM-CSF, IL-2 i.v.)

    Terminated
    • Neuroblastoma
    • antibody ch14.18
    • +4 more
    • Cologne, Germany
      University of Cologne
    Nov 3, 2022

    Neuroblastoma Trial in Minneapolis (Thiotepa, Cyclophosphamide, Melphalan)

    Recruiting
    • Neuroblastoma
    • Minneapolis, Minnesota
      Masonic Cancer Center, University of Minnesota
    Nov 2, 2022

    Neuroblastoma Trial in Worldwide (Data-collection)

    Recruiting
    • Neuroblastoma
    • Data-collection
    • Wien,, Vienna, Austria
    • +13 more
    Oct 28, 2022

    Ewing Sarcoma, Rhabdomyosarcoma, Wilms Tumor Trial in Valhalla (Vorinostat)

    Recruiting
    • Ewing Sarcoma
    • +5 more
    • Valhalla, New York
      New York Medical College
    Oct 24, 2022

    Neuroblastoma, Pediatric Solid Tumor Trial in Boston (procedure, biological, drug)

    Recruiting
    • Neuroblastoma
    • Pediatric Solid Tumor
    • Tissue collection
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Oct 17, 2022

    Neuroendocrine Tumors, Meningioma, Neuroblastoma Trial in Iowa City (radiation, diagnostic test, drug)

    Active, not recruiting
    • Neuroendocrine Tumors
    • +3 more
    • 90Y-DOTA tyr3-Octreotide
    • +2 more
    • Iowa City, Iowa
      University of Iowa Hospitals and Clinics
    Oct 6, 2022

    Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma Trial in Atlanta (Ex Vivo Expanded Allogeneic ?d T Cells in

    Not yet recruiting
    • Neuroblastoma
    • +2 more
    • Ex Vivo Expanded Allogeneic γδ T Cells in Combination with Dinutuximab, Temozolomide, Irinotecan and Zoledronate
    • Atlanta, Georgia
      Children's Healthcare of Atlanta
    Oct 6, 2022